KeyBank National Association’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,683
| Closed | -$388K | – | 1059 |
|
|
2023
Q2 | $388K | Buy |
9,683
+1,030
| +12% | +$41.3K | ﹤0.01% | 794 |
|
|
2023
Q1 | $353K | Sell |
8,653
-74
| -0.8% | -$3.02K | ﹤0.01% | 836 |
|
|
2022
Q4 | $337K | Buy |
8,727
+530
| +6% | +$20.5K | ﹤0.01% | 838 |
|
|
2022
Q3 | $436K | Buy |
8,197
+1,924
| +31% | +$102K | ﹤0.01% | 706 |
|
|
2022
Q2 | $366K | Sell |
6,273
-302
| -5% | -$17.6K | ﹤0.01% | 804 |
|
|
2022
Q1 | $502K | Buy |
6,575
+18
| +0.3% | +$1.37K | ﹤0.01% | 726 |
|
|
2021
Q4 | $395K | Hold |
6,557
| – | – | ﹤0.01% | 856 |
|
|
2021
Q3 | $367K | Hold |
6,557
| – | – | ﹤0.01% | 886 |
|
|
2021
Q2 | $398K | Hold |
6,557
| – | – | ﹤0.01% | 854 |
|
|
2021
Q1 | $460K | Sell |
6,557
-3
| -0% | -$210 | ﹤0.01% | 815 |
|
|
2020
Q4 | $393K | Hold |
6,560
| – | – | ﹤0.01% | 830 |
|
|
2020
Q3 | $394K | Buy |
6,560
+27
| +0.4% | +$1.62K | ﹤0.01% | 756 |
|
|
2020
Q2 | $343K | Buy |
6,533
+33
| +0.5% | +$1.73K | ﹤0.01% | 780 |
|
|
2020
Q1 | $218K | Sell |
6,500
-1,962
| -23% | -$65.8K | ﹤0.01% | 838 |
|
|
2019
Q4 | $383K | Buy |
8,462
+17
| +0.2% | +$769 | ﹤0.01% | 801 |
|
|
2019
Q3 | $321K | Sell |
8,445
-40
| -0.5% | -$1.52K | ﹤0.01% | 824 |
|
|
2019
Q2 | $369K | Hold |
8,485
| – | – | ﹤0.01% | 814 |
|
|
2019
Q1 | $323K | Buy |
8,485
+98
| +1% | +$3.73K | ﹤0.01% | 805 |
|
|
2018
Q4 | $361K | Sell |
8,387
-24
| -0.3% | -$1.03K | ﹤0.01% | 742 |
|
|
2018
Q3 | $413K | Hold |
8,411
| – | – | ﹤0.01% | 818 |
|
|
2018
Q2 | $270K | Hold |
8,411
| – | – | ﹤0.01% | 908 |
|
|
2018
Q1 | $262K | Hold |
8,411
| – | – | ﹤0.01% | 914 |
|
|
2017
Q4 | $384K | Buy |
+8,411
| New | +$384K | ﹤0.01% | 821 |
|